DATA
VISIT DATA
Here are the gold-standard databases and data visualizations of R&D funding, approved products and candidates in the pipeline for neglected diseases, emerging infectious diseases and maternal health.
G-FINDER
G-FINDER
The annual tracker of R&D investment into new drugs, vaccines, diagnostics and vector control products for global health.
Infectious Disease R&D Tracker
Candidates in the pipeline and approved products for global health priorities across neglected diseases and emerging infectious diseases.
Maternal Health Pipeline
Database profiling medicines, diagnostics, and devices for seven significant pregnancy-related conditions.
Snakebite Envenoming Medicines Database
Database of all snakebite envenoming medicines with direct action on toxins.
Sexually Transmitted Infections Pipeline
Database of critical products for three STIs with an AMR risk.
Gynaecological Conditions Pipeline
Database of women's health products for three significant gynaecological conditions.
Innovation Spillover Tracker
A tracker of health innovations developed for LMICs that have translated into new applications and benefits in HICs.
INSIGHTS
VISIT INSIGHTS
Here you will find the analysis and insights to support decisions - whether you're funding research, setting policies, developing products or advocating for change.
Explore our hubs
The Investment Landscape Hub
A unique source of data and analysis tracking the funding of global health R&D and the pipeline of products in development. Powered by G-FINDER.
The Impact of Global Health R&D Hub
Global, UK and EU analyses of the health and economic impact of the last two decades of investment in global health R&D.
Women's Health Hub
This resource hub provides a suite of data, insights and tools to accelerate progress in women’s health R&D
Report Library
Our reports deliver critical insights using the evidence collected through G-FINDER and over two decades of independent analysis.
Health areas
This quick reference guide gives you a snapshot analysis of the R&D needs and the state of innovation to tackle each disease or condition we cover. It's a handy quick overview of what's needed to impact global health in these areas.
Hubs
Themed collections of all the data, analysis and tools you need to understand the landscape and make smart decisions on global health R&D.
Impact Global Health Dialogues
A series of dialogues with global health leaders to co-create an R&D investment roadmap that is fit for the future.
TOOLS
VISIT TOOLS
We've created some practical frameworks and tools you can use to assess and increase impact in global health.
Advocacy Kits
Join us in creating global health impact with our advocacy and press kits
Impact Framework
A global network of experts collaborated for two years to develop this comprehensive set of metrics that create an impact assessment framework for global health R&D.
100 Days Mission Scorecard
Is the world ready to deploy a new product to tackle an epidemic within 100 days of an outbreak?
ABOUT US
VISIT ABOUT US
Meet the team working to create a more equitable future through global health innovation and impact.
Our Team
Meet our diverse international team of experts, who collate and analyse data on global health funding and the innovation pipeline
Our Global Advisory Council
Bringing together some of the leading and most influential figures in global health, our Council challenges our thinking, expands our foresight and helps us with horizon scanning
Join Us
We build bridges, partnerships and consensus across the complex ecosystem of global health R&D players. Find out how to partner with us, commission our expertise, and how to join our team when we have vacancies.
Contact Us
Please get in touch with any questions or feedback. Between us, we cover most time zones so one of us will get back to you quickly.
Advocacy Kits
Join us in creating global health impact with our advocacy and press kits
NEWS

The Ripple Effect 2.0: video

By Impact Global Health 20 January 2026

5 min read

Neglected DiseasesEmerging Infectious DiseasesSexual & Reproductive HealthPost-partum haemorrhage (PPH)

Key messages from the report

Global health R&D delivers extraordinary returns for everyone: saving lives, strengthening economics and accelerating scientific progress. Our previous Ripple Effect report showed that $71 billion invested in global health R&D funding from 2007–2023 catalyzed $511 billion in GDP growth, 643,000 jobs, and 20,000 patents, a multiplier effect proving that global health investment drives domestic prosperity.

Building on this macro-level evidence, The Ripple Effect 2.0 moves a step further by measuring product-specific health and economic impacts in HICs. It focuses on three case studies: the shingles vaccine (Shingrix), the JADA System for postpartum haemorrhage, and BCG as a treatment for bladder cancer.

The report provides quantitative, country-specific proof points showing how innovations originally developed to address health needs in low- and middle-income countries (LMICs) are now improving health outcomes and delivering economic value across the United States, United Kingdom, Japan, and Europe.

Take a look at this video of the key messages:

Read the report

The Ripple Effect 2.0: video

Table of contents

Key messages from the report